ASSET ACQUISITIONS AND STRATEGIC TRANSACTIONS - Additional Information (Details) - USD ($) $ in Thousands |
Oct. 14, 2025 |
Jun. 30, 2026 |
Dec. 31, 2025 |
Oct. 28, 2025 |
|---|---|---|---|---|
| Business Combination [Line Items] | ||||
| Carrying amount of the redeemable NCI | $ 0 | $ 0 | ||
| Bridge Health | ||||
| Business Combination [Line Items] | ||||
| Equity interests ownersip acquired | 100.00% | 100.00% | ||
| Milestone payments for development and regulatory milestones | $ 3,900 | |||
| VIS-101 | AffaMed | ||||
| Business Combination [Line Items] | ||||
| Payment for ex-China rights to VIS-101 | $ 5,000 | |||
| Carrying amount of the redeemable NCI | $ 0 | $ 0 |
| X | ||||||||||
- Definition Milestone payments for development and regulatory milestones. No definition available.
|
| X | ||||||||||
- Definition Payment for product rights. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
| X | ||||||||||
- Definition As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|